Menstruation disturbances, female gonadal disorders

PubMed Free Full Text

Polycystic ovary syndrome: epidemiology, etiology, diagnosis

China

• Annals of Palliative Medicine
  • The prevalence of polycystic ovarian syndrome in Chinese women: a meta-analysis [2021]

• Lancet Regional Health – Western Pacific
  • Changes in the prevalence of polycystic ovary syndrome in China over the past decade [2022]

Europe

• Archives of Medical Science : AMS
  • National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016 [2019]

India

• Nepal Journal of Epidemiology
  • Polycystic ovary syndrome among Indian adolescent girls – A systematic review and metanalysis [2021]

International

• Androgen Excess and PCOS Society
  • Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource [2019]
  • The Diagnosis of Polycystic Ovary Syndrome during Adolescence [2015]
  • Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society [2013]
  • Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society [2010]
  • The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [2009]
  • Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society [2007]

• Frontiers in Endocrinology
  • Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis [2022]

• Human Reproduction
  • Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017 [2021]
  • The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis [2016]

• Journal of Human Reproductive Sciences
  • The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review [2020]

• Oncotarget
  • The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis [2017]

Iran

• Iranian Journal of Reproductive Medicine
  • Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis [2015]

Latin America

• Frontiers in Endocrinology
  • Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review [2021]

Qatar

• PLoS ONE
  • The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population [2017]

Republic of Korea

• BMC Women's Health
  • Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database [2022]

• PLoS ONE
  • Prevalence of Metabolic Syndrome Is Higher among Non-Obese PCOS Women with Hyperandrogenism and Menstrual Irregularity in Korea [2014]

• Yonsei Medical Journal
  • Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010-2019) [2022]

Singapore

• Annals Academy of Medicine Singapore
  • Diagnosis and management of polycystic ovary syndrome: Perspectives of clinicians in Singapore [2022]

Taiwan

• Clinical and Experimental Reproductive Medicine
  • Clinical characteristics in Taiwanese women with polycystic ovary syndrome [2015]

• International Journal of Environmental Research and Public Health
  • Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis [2019]

United States

• Endocrine Society
  • Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome [2015]

• Fertility and Sterility
  • Specificity and Predictive Value of Circulating Testosterone Assessed By Tandem Mass Spectrometry for the Diagnosis of Polycystic Ovary Syndrome by the NIH 1990 Criteria [2014]

{Related topics}

• Topic
  • Polycystic ovary syndrome